1
|
Starzonek S, Maar H, Mereiter S, Freytag V, Haider MT, Riecken K, Huang YL, Jacob F, Wicklein D, Schumacher U, Lange T. Identification of potential classes of glycoligands mediating dynamic endothelial adhesion of human tumor cells. Glycobiology 2023; 33:637-650. [PMID: 37486674 PMCID: PMC10560084 DOI: 10.1093/glycob/cwad061] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/17/2023] [Revised: 07/12/2023] [Accepted: 07/17/2023] [Indexed: 07/25/2023] Open
Abstract
One critical step of metastasis formation is the extravasation of circulating tumor cells from the bloodstream. This process requires the dynamic interaction of cell adhesion molecules like E-selectin on endothelial cells with carbohydrate ligands on tumor cells. To characterize these glycans in a comprehensible approach, the rolling, tethering, and firm adhesion of nine human tumor cell lines on human umbilical vein endothelial cells was analyzed using laminar flow adhesion assays. The tumor cell lines were grouped into three subsets by their canonical E-selectin ligand status (sialyl-Lewis A and X +/+, -/+, -/-) and their adhesiveness was compared after enzymatic, pharmacologic, chemical treatment or antibody blockade of the tumor cells or endothelial cells, respectively. Tumor cells were also screened regarding their glycosyltransferase expression profile. We found that although E-selectin and terminal α2,3-sialic acid largely determined firm adhesion, adhesive events did not exclusively depend on the presence of sialyl-Lewis A and/or sialyl-Lewis X. Nevertheless, two of the three sialyl-Lewis A/X-/- tumor cells additionally or fully depended on vascular cell adhesion molecule-1 for firm adhesion. The significance of O-GalNAc- and N-glycans for adhesion varied remarkably among the tumor cells. The sialyl-Lewis A/X+/+ subset showed glycoprotein-independent adhesion, suggesting a role of glycolipids as well. All sialyl-Lewis A/X-/- tumor cells lacked FUT3 and FUT7 expression as opposed to sialyl-Lewis A/X+/+ or -/+ cell lines. In summary, the glycans on tumor cells mediating endothelial adhesion are not as much restricted to sialyl-Lewis A /X as previously assumed. The present study specifically suggests α2,3-linked sialic acid, O-GalNAc glycans, glycosphingolipids, and FUT3/FUT7 products as promising targets for future studies.
Collapse
Affiliation(s)
- Sarah Starzonek
- Institute of Anatomy & Experimental Morphology, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246 Hamburg, Germany
| | - Hanna Maar
- Institute of Anatomy & Experimental Morphology, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246 Hamburg, Germany
- Institute of Anatomy I, University Hospital Jena, Teichgraben 7, 07743 Jena, Germany
- Comprehensive Cancer Center Central Germany (CCCG), 07743 Jena, Germany
| | - Stefan Mereiter
- Institute of Molecular Biotechnology, Austrian Academy of Sciences, Dr. Bohr-Gasse 3, 1030 Vienna, Austria
| | - Vera Freytag
- Institute of Anatomy & Experimental Morphology, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246 Hamburg, Germany
| | - Marie-Therese Haider
- Institute of Anatomy & Experimental Morphology, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246 Hamburg, Germany
| | - Kristoffer Riecken
- Research Department Cell and Gene Therapy, Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246 Hamburg, Germany
| | - Yen-Lin Huang
- Ovarian Cancer Research, University Hospital Basel and University of Basel, Hebelstrasse 20, 4031 Basel, Switzerland
| | - Francis Jacob
- Ovarian Cancer Research, University Hospital Basel and University of Basel, Hebelstrasse 20, 4031 Basel, Switzerland
| | - Daniel Wicklein
- Institute of Anatomy & Experimental Morphology, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246 Hamburg, Germany
- Department of Anatomy and Cell Biology, University of Marburg, Robert-Koch-Strasse 8, 35037 Marburg, Germany
| | - Udo Schumacher
- Institute of Anatomy & Experimental Morphology, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246 Hamburg, Germany
- Medical School Berlin, Leipziger Platz 10, 10117 Berlin, Germany
| | - Tobias Lange
- Institute of Anatomy & Experimental Morphology, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246 Hamburg, Germany
- Institute of Anatomy I, University Hospital Jena, Teichgraben 7, 07743 Jena, Germany
- Comprehensive Cancer Center Central Germany (CCCG), 07743 Jena, Germany
| |
Collapse
|
2
|
Shen D, Lu X, Li W, Zou L, Tong Y, Wang L, Rao L, Zhang Y, Hou L, Sun G, Chen L. Identification and characterization of an α-1,3 mannosidase from Elizabethkingia meningoseptica and its potential attenuation impact on allergy associated with cross-reactive carbohydratedeterminant. Biochem Biophys Res Commun 2023; 672:17-26. [PMID: 37331167 DOI: 10.1016/j.bbrc.2023.06.035] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/28/2023] [Accepted: 06/10/2023] [Indexed: 06/20/2023]
Abstract
Core α-1,3 mannose is structurally near the core xylose and core fucose on core pentasaccharide from plant and insect glycoproteins. Mannosidase is a useful tool for characterization the role of core α-1,3 mannose in the composition of glycan related epitope, especially for those epitopes in which core xylose and core fucose are involved. Through functional genomic analysis, we identified a glycoprotein α-1,3 mannosidase and named it MA3. We used MA3 to treat allergen horseradish peroxidase (HRP) and phospholipase A2 (PLA2) separately. The results showed that after MA3 removed α-1,3 mannose on HRP, the reactivity of HRP with anti-core xylose polyclonal antibody almost disappeared. And the reactivity of MA3-treated PLA2 with anti-core fucose polyclonal antibody decreased partially. In addition, when PLA2 was conducted enzyme digestion by MA3, the reactivity between PLA2 and allergic patients' sera diminished. These results demonstrated that α-1,3 mannose was an critical component of glycan related epitope.
Collapse
Affiliation(s)
- Danfeng Shen
- Dept. of Medical Microbiology, Key Laboratory of Medical Molecular Virology of Ministries of Education and Health, School of Basic Medical Sciences, Fudan University, Shanghai, 200032, China
| | - Xinrong Lu
- Dept. of Medical Microbiology, Key Laboratory of Medical Molecular Virology of Ministries of Education and Health, School of Basic Medical Sciences, Fudan University, Shanghai, 200032, China
| | - Wenjie Li
- Clinical Laboratory, The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, 310053, Zhejiang Province, China
| | - Lin Zou
- Dept. of Medical Microbiology, Key Laboratory of Medical Molecular Virology of Ministries of Education and Health, School of Basic Medical Sciences, Fudan University, Shanghai, 200032, China
| | - Yongliang Tong
- Dept. of Medical Microbiology, Key Laboratory of Medical Molecular Virology of Ministries of Education and Health, School of Basic Medical Sciences, Fudan University, Shanghai, 200032, China
| | - Lei Wang
- Department of Research and Development, SysDiagno Biomedtech, Nanjing, 211800, Jiangsu Province, China
| | - Lin Rao
- Dept. of Medical Microbiology, Key Laboratory of Medical Molecular Virology of Ministries of Education and Health, School of Basic Medical Sciences, Fudan University, Shanghai, 200032, China
| | - Yuxin Zhang
- School of Medical Technology and Information Engineering, Zhejiang Chinese Medical University, Hangzhou, 310053, Zhejiang Province, China
| | - Linlin Hou
- College of Veterinary Medicine, Qingdao Agricultural University, Qingdao, 266109, Shandong Province, China.
| | - Guiqin Sun
- School of Medical Technology and Information Engineering, Zhejiang Chinese Medical University, Hangzhou, 310053, Zhejiang Province, China.
| | - Li Chen
- Dept. of Medical Microbiology, Key Laboratory of Medical Molecular Virology of Ministries of Education and Health, School of Basic Medical Sciences, Fudan University, Shanghai, 200032, China.
| |
Collapse
|
3
|
Guan B, Chai Y, Amantai X, Chen X, Cao X, Yue X. A new sight to explore site-specific N-glycosylation in donkey colostrum milk fat globule membrane proteins with glycoproteomics analysis. Food Res Int 2022; 162:111938. [DOI: 10.1016/j.foodres.2022.111938] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/10/2022] [Revised: 09/10/2022] [Accepted: 09/12/2022] [Indexed: 11/04/2022]
|
4
|
Androgen Receptor Splice Variants Contribute to the Upregulation of DNA Repair in Prostate Cancer. Cancers (Basel) 2022; 14:cancers14184441. [PMID: 36139600 PMCID: PMC9496991 DOI: 10.3390/cancers14184441] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/18/2022] [Revised: 09/06/2022] [Accepted: 09/07/2022] [Indexed: 11/17/2022] Open
Abstract
Background: Canonical androgen receptor (AR) signaling regulates a network of DNA repair genes in prostate cancer (PCA). Experimental and clinical evidence indicates that androgen deprivation not only suppresses DNA repair activity but is often synthetically lethal in combination with PARP inhibition. The present study aimed to elucidate the impact of AR splice variants (AR-Vs), occurring in advanced or late-stage PCA, on DNA repair machinery. Methods: Two hundred and seventy-three tissue samples were analyzed, including primary hormone-naïve PCA, primary metastases, hormone-sensitive PCA on androgen deprivation therapy (ADT) and castration refractory PCA (CRPC group). The transcript levels of the target genes were profiled using the nCounter platform. Experimental support for the findings was gained in AR/AR-V7-expressing LNCaP cells subjected to ionizing radiation. Results: AR-Vs were present in half of hormone-sensitive PCAs on androgen deprivation therapy (ADT) and two-thirds of CRPC samples. The presence of AR-Vs is highly correlated with increased activity in the AR pathway and DNA repair gene expression. In AR-V-expressing CRPC, the DNA repair score increased by 2.5-fold as compared to AR-V-negative samples. Enhanced DNA repair and the deregulation of DNA repair genes by AR-V7 supported the clinical data in a cell line model. Conclusions: The expression of AR splice variants such as AR-V7 in PCA patients following ADT might be a reason for reduced or absent therapy effects in patients on additional PARP inhibition due to the modulation of DNA repair gene expression. Consequently, AR-Vs should be further studied as predictive biomarkers for therapy response in this setting.
Collapse
|
5
|
Robakiewicz S, Bridot C, Serna S, Gimeno A, Echeverria B, Delgado S, Ruyck J, Semwal S, Charro D, Dansercoer A, Verstraete K, Azkargorta M, Noort K, Wilbers R, Savvides SN, Abrescia NGA, Arda A, Reichardt NC, Jiménez-Barbero J, Bouckaert J. Minimal epitope for Mannitou IgM on paucimannose-carrying glycoproteins. Glycobiology 2021; 31:1005-1017. [PMID: 33909073 DOI: 10.1093/glycob/cwab027] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/15/2021] [Revised: 03/03/2021] [Accepted: 03/30/2021] [Indexed: 11/14/2022] Open
Abstract
Paucimannosidic glycans are restricted to the core structure [Man1-3GlcNAc2Fuc0-1] of N-glycans and are rarely found in mammalian tissues. Yet, especially [Man2-3GlcNAc2Fuc1] have been found significantly upregulated in tumors, including in colorectal and liver cancer. Mannitou IgM is a murine monoclonal antibody that was previously shown to recognise Man3GlcNAc2 with an almost exclusive selectivity. Here, we have sought the definition of the minimal glycan epitope of Mannitou IgM, initiated by screening on a newly designed paucimannosidic glycan microarray. Among the best binders were Man3GlcNAc2 and its α1,6 core-fucosylated variant, Man3GlcNAc2Fuc1. Unexpectedly and in contrast to earlier findings, Man5GlcNAc2-type structures bind equally well and a large tolerance was observed for substitutions on the α1,6 arm. It was confirmed that any substitution on the single α1,3-linked mannose completely abolishes binding. Surface plasmon resonance for kinetic measurements of Mannitou IgM binding, either directly on the glycans or as presented on omega-1 and kappa-5 soluble egg antigens from the helminth parasite Schistosoma mansoni, showed submicromolar affinities. To characterize the epitope in greater and atomic detail, saturation transfer difference nuclear magnetic resonance spectroscopy was performed with the Mannitou antigen-binding fragment. The STD-NMR data demonstrated the strongest interactions with the aliphatic protons H1 and H2 of the α1-3-linked mannose, and weaker imprints on its H3, H4 and H5 protons. In conclusion, Mannitou IgM binding requires a non-substituted α1,3-linked mannose branch of paucimannose also on proteins, making it a highly specific tool for the distinction of concurrent human tumor-associated carbohydrate antigens.
Collapse
Affiliation(s)
- Stefania Robakiewicz
- Unité de Glycobiologie Structurale et Fonctionnelle, UMR 8576 du CNRS et Université de Lille, 50 Avenue Halley, 59650 Villeneuve d'Ascq, France
| | - Clarisse Bridot
- Unité de Glycobiologie Structurale et Fonctionnelle, UMR 8576 du CNRS et Université de Lille, 50 Avenue Halley, 59650 Villeneuve d'Ascq, France
| | - Sonia Serna
- Glycotechnology Laboratory, Center for Cooperative Research in Biomaterials (CIC biomaGUNE), Basque Research and Technology Alliance (BRTA), Paseo Miramón 182, 20014 San Sebastian, Spain
| | - Ana Gimeno
- CIC bioGUNE, Bizkaia Science and Technology Park, 48160 Derio, Spain
| | - Begoña Echeverria
- Glycotechnology Laboratory, Center for Cooperative Research in Biomaterials (CIC biomaGUNE), Basque Research and Technology Alliance (BRTA), Paseo Miramón 182, 20014 San Sebastian, Spain
| | - Sandra Delgado
- CIC bioGUNE, Bizkaia Science and Technology Park, 48160 Derio, Spain
| | - Jérôme Ruyck
- Unité de Glycobiologie Structurale et Fonctionnelle, UMR 8576 du CNRS et Université de Lille, 50 Avenue Halley, 59650 Villeneuve d'Ascq, France
| | - Shubham Semwal
- Unité de Glycobiologie Structurale et Fonctionnelle, UMR 8576 du CNRS et Université de Lille, 50 Avenue Halley, 59650 Villeneuve d'Ascq, France
| | - Diego Charro
- CIC bioGUNE, Bizkaia Science and Technology Park, 48160 Derio, Spain
| | - Ann Dansercoer
- Unit for Structural Biology, VIB - UGent Center for Inflammation Research, Department of Biochemistry and Microbiology, Ghent University, Technologiepark 71, 9052 Ghent, Belgium
| | - Kenneth Verstraete
- Unit for Structural Biology, VIB - UGent Center for Inflammation Research, Department of Biochemistry and Microbiology, Ghent University, Technologiepark 71, 9052 Ghent, Belgium
| | - Mikel Azkargorta
- CIC bioGUNE, Bizkaia Science and Technology Park, 48160 Derio, Spain
| | - Kim Noort
- Laboratory of Nematology, Plant Science Group, Wageningen University and Research, Droevendaalsesteeg 1, 6708 PB Wageningen, The Netherlands
| | - Ruud Wilbers
- Laboratory of Nematology, Plant Science Group, Wageningen University and Research, Droevendaalsesteeg 1, 6708 PB Wageningen, The Netherlands
| | - Savvas N Savvides
- Unit for Structural Biology, VIB - UGent Center for Inflammation Research, Department of Biochemistry and Microbiology, Ghent University, Technologiepark 71, 9052 Ghent, Belgium
| | - Nicola G A Abrescia
- CIC bioGUNE, Bizkaia Science and Technology Park, 48160 Derio, Spain.,IKERBASQUE, Basque Foundation for Science, 48009 Bilbao, Spain
| | - Ana Arda
- CIC bioGUNE, Bizkaia Science and Technology Park, 48160 Derio, Spain
| | - Niels C Reichardt
- Glycotechnology Laboratory, Center for Cooperative Research in Biomaterials (CIC biomaGUNE), Basque Research and Technology Alliance (BRTA), Paseo Miramón 182, 20014 San Sebastian, Spain
| | - Jesús Jiménez-Barbero
- CIC bioGUNE, Bizkaia Science and Technology Park, 48160 Derio, Spain.,IKERBASQUE, Basque Foundation for Science, 48009 Bilbao, Spain
| | - Julie Bouckaert
- Unité de Glycobiologie Structurale et Fonctionnelle, UMR 8576 du CNRS et Université de Lille, 50 Avenue Halley, 59650 Villeneuve d'Ascq, France
| |
Collapse
|
6
|
Hinneburg H, Pedersen JL, Bokil NJ, Pralow A, Schirmeister F, Kawahara R, Rapp E, Saunders BM, Thaysen-Andersen M. High-resolution longitudinal N- and O-glycoprofiling of human monocyte-to-macrophage transition. Glycobiology 2020; 30:679-694. [DOI: 10.1093/glycob/cwaa020] [Citation(s) in RCA: 17] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/18/2019] [Revised: 02/18/2020] [Accepted: 03/02/2020] [Indexed: 12/12/2022] Open
Abstract
Abstract
Protein glycosylation impacts the development and function of innate immune cells. The glycophenotypes and the glycan remodelling associated with the maturation of macrophages from monocytic precursor populations remain incompletely described. Herein, label-free porous graphitised carbon–liquid chromatography–tandem mass spectrometry (PGC-LC-MS/MS) was employed to profile with high resolution the N- and O-glycome associated with human monocyte-to-macrophage transition. Primary blood-derived CD14+ monocytes were differentiated ex vivo in the absence of strong anti- and proinflammatory stimuli using a conventional 7-day granulocyte-macrophage colony-stimulating factor differentiation protocol with longitudinal sampling. Morphology and protein expression monitored by light microscopy and proteomics validated the maturation process. Glycomics demonstrated that monocytes and macrophages display similar N-glycome profiles, comprising predominantly paucimannosidic (Man1-3GlcNAc2Fuc0–1, 22.1–30.8%), oligomannosidic (Man5-9GlcNAc2, 29.8–35.7%) and α2,3/6-sialylated complex-type N-glycans with variable core fucosylation (27.6–39.1%). Glycopeptide analysis validated conjugation of these glycans to human proteins, while quantitative proteomics monitored the glycoenzyme expression levels during macrophage differentiation. Significant interperson glycome variations were observed suggesting a considerable physiology-dependent or heritable heterogeneity of CD14+ monocytes. Only few N-glycome changes correlated with the monocyte-to-macrophage transition across donors including decreased core fucosylation and reduced expression of mannose-terminating (paucimannosidic-/oligomannosidic-type) N-glycans in macrophages, while lectin flow cytometry indicated that more dramatic cell surface glycan remodelling occurs during maturation. The less heterogeneous core 1-rich O-glycome showed a minor decrease in core 2-type O-glycosylation but otherwise remained unchanged with macrophage maturation. This high-resolution glycome map underpinning normal monocyte-to-macrophage transition, the most detailed to date, aids our understanding of the molecular makeup pertaining to two vital innate immune cell types and forms an important reference for future glycoimmunological studies.
Collapse
Affiliation(s)
- Hannes Hinneburg
- Department of Molecular Sciences, Macquarie University, NSW 2109 Sydney, Australia
- Biomolecular Discovery Research Centre, Macquarie University, NSW 2109 Sydney, Australia
| | - Jessica L Pedersen
- School of Life Sciences, Faculty of Science, University of Technology, NSW 2007 Sydney, Australia
| | - Nilesh J Bokil
- School of Life Sciences, Faculty of Science, University of Technology, NSW 2007 Sydney, Australia
| | - Alexander Pralow
- Max Planck Institute for Dynamics of Complex Technical Systems (Bioprocess Engineering), 39106 Magdeburg, Germany
| | | | - Rebeca Kawahara
- Department of Molecular Sciences, Macquarie University, NSW 2109 Sydney, Australia
- Biomolecular Discovery Research Centre, Macquarie University, NSW 2109 Sydney, Australia
| | - Erdmann Rapp
- Max Planck Institute for Dynamics of Complex Technical Systems (Bioprocess Engineering), 39106 Magdeburg, Germany
- GlyXera GmbH, 39120 Magdeburg, Germany
| | - Bernadette M Saunders
- School of Life Sciences, Faculty of Science, University of Technology, NSW 2007 Sydney, Australia
| | - Morten Thaysen-Andersen
- Department of Molecular Sciences, Macquarie University, NSW 2109 Sydney, Australia
- Biomolecular Discovery Research Centre, Macquarie University, NSW 2109 Sydney, Australia
| |
Collapse
|
7
|
Increased Expression of Immature Mannose-Containing Glycoproteins and Sialic Acid in Aged Mouse Brains. Int J Mol Sci 2019; 20:ijms20246118. [PMID: 31817246 PMCID: PMC6940728 DOI: 10.3390/ijms20246118] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/31/2019] [Revised: 11/26/2019] [Accepted: 12/02/2019] [Indexed: 12/15/2022] Open
Abstract
Aging represents the accumulation of changes in an individual over time, encompassing physical, psychological, and social changes. Posttranslational modifications of proteins such as glycosylation, including sialylation or glycation, are proposed to be involved in this process, since they modulate a variety of molecular and cellular functions. In this study, we analyzed selected posttranslational modifications and the respective proteins on which they occur in young and old mouse brains. The expression of neural cell adhesion molecule (NCAM), receptor for advanced glycation endproducts (RAGE), as well as the carbohydrate-epitopes paucimannose and high-mannose, polysialic acid, and O-GlcNAc were examined. We demonstrated that mannose-containing glycans increased on glycoproteins in aged mouse brains and identified synapsin-1 as one major carrier of paucimannose in aged brains. In addition, we found an accumulation of so-called advanced glycation endproducts, which are generated by non-enzymatic reactions and interfere with protein function. Furthermore, we analyzed the expression of sialic acid and found also an increase during aging.
Collapse
|
8
|
Chatterjee S, Lee LY, Kawahara R, Abrahams JL, Adamczyk B, Anugraham M, Ashwood C, Sumer‐Bayraktar Z, Briggs MT, Chik JHL, Everest‐Dass A, Förster S, Hinneburg H, Leite KRM, Loke I, Möginger U, Moh ESX, Nakano M, Recuero S, Sethi MK, Srougi M, Stavenhagen K, Venkatakrishnan V, Wongtrakul‐Kish K, Diestel S, Hoffmann P, Karlsson NG, Kolarich D, Molloy MP, Muders MH, Oehler MK, Packer NH, Palmisano G, Thaysen‐Andersen M. Protein Paucimannosylation Is an EnrichedN‐Glycosylation Signature of Human Cancers. Proteomics 2019; 19:e1900010. [DOI: 10.1002/pmic.201900010] [Citation(s) in RCA: 36] [Impact Index Per Article: 7.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/29/2019] [Revised: 07/25/2019] [Indexed: 01/01/2023]
Affiliation(s)
- Sayantani Chatterjee
- Department of Molecular Sciences and Biomolecular Discovery and Design Research Centre (BDDRC) Macquarie University Sydney 2109 Australia
| | - Ling Y. Lee
- Department of Molecular Sciences and Biomolecular Discovery and Design Research Centre (BDDRC) Macquarie University Sydney 2109 Australia
- ISGlobal, Barcelona Centre for International Health Research (CRESIB) Hospital Clínic–Universitat de Barcelona Barcelona 08193 Spain
| | - Rebeca Kawahara
- Department of Molecular Sciences and Biomolecular Discovery and Design Research Centre (BDDRC) Macquarie University Sydney 2109 Australia
- Department of Parasitology, Institute of Biomedical Sciences University of São Paulo São Paulo 01000 Brazil
| | - Jodie L. Abrahams
- Department of Molecular Sciences and Biomolecular Discovery and Design Research Centre (BDDRC) Macquarie University Sydney 2109 Australia
- Institute for Glycomics, Griffith University Gold Coast 4222 Australia
| | - Barbara Adamczyk
- Department of Medical Biochemistry and Cell Biology Institute of Biomedicine, Sahlgrenska Academy University of Gothenburg Gothenburg SE 405 30 Sweden
| | - Merrina Anugraham
- Department of Molecular Sciences and Biomolecular Discovery and Design Research Centre (BDDRC) Macquarie University Sydney 2109 Australia
- Institute of Biological Chemistry Academia Sinica Taipei 11529 Taiwan
| | - Christopher Ashwood
- Department of Molecular Sciences and Biomolecular Discovery and Design Research Centre (BDDRC) Macquarie University Sydney 2109 Australia
- Department of Biochemistry Medical College of Wisconsin Milwaukee WI 53226 USA
| | - Zeynep Sumer‐Bayraktar
- Department of Molecular Sciences and Biomolecular Discovery and Design Research Centre (BDDRC) Macquarie University Sydney 2109 Australia
- School of Life and Environmental Sciences Charles Perkins Centre (CPC), The University of Sydney Sydney 2006 Australia
| | - Matthew T. Briggs
- Future Industries Institute Mawson Lakes Campus, University of South Australia Adelaide 5005 Australia
| | - Jenny H. L. Chik
- Department of Molecular Sciences and Biomolecular Discovery and Design Research Centre (BDDRC) Macquarie University Sydney 2109 Australia
- International Collaboration on Repair Discoveries Vancouver Coastal Health Research Institute and Department of Pathology and Laboratory Medicine The University of British Columbia Vancouver BC V6T 1Z4 Canada
| | - Arun Everest‐Dass
- Department of Molecular Sciences and Biomolecular Discovery and Design Research Centre (BDDRC) Macquarie University Sydney 2109 Australia
- Institute for Glycomics, Griffith University Gold Coast 4222 Australia
| | - Sarah Förster
- Rudolf‐Becker‐Laboratory Institute of Pathology University Hospital Bonn Bonn 53127 Germany
| | - Hannes Hinneburg
- Department of Molecular Sciences and Biomolecular Discovery and Design Research Centre (BDDRC) Macquarie University Sydney 2109 Australia
| | - Katia R. M. Leite
- Laboratório de Investigação Médica da Disciplina de Urologia (LIM55) Faculdade de Medicina da FMUSP Universidade de Sao Paulo São Paulo 01000 Brazil
| | - Ian Loke
- Department of Molecular Sciences and Biomolecular Discovery and Design Research Centre (BDDRC) Macquarie University Sydney 2109 Australia
- Department of Biological Sciences National University of Singapore Singapore 119077 Singapore
| | - Uwe Möginger
- Department for Biochemistry and Molecular Biology University of Southern Denmark Odense 5230 Denmark
| | - Edward S. X. Moh
- Department of Molecular Sciences and Biomolecular Discovery and Design Research Centre (BDDRC) Macquarie University Sydney 2109 Australia
- ARC Centre for Nanoscale Biophotonics Macquarie University Sydney 2109 Australia
| | - Miyako Nakano
- Department of Molecular Sciences and Biomolecular Discovery and Design Research Centre (BDDRC) Macquarie University Sydney 2109 Australia
- Graduate School of Advanced Sciences of Matter Hiroshima University Hiroshima 739‐8527 Japan
| | - Saulo Recuero
- Laboratório de Investigação Médica da Disciplina de Urologia (LIM55) Faculdade de Medicina da FMUSP Universidade de Sao Paulo São Paulo 01000 Brazil
| | - Manveen K. Sethi
- Department of Molecular Sciences and Biomolecular Discovery and Design Research Centre (BDDRC) Macquarie University Sydney 2109 Australia
- Center for Biomedical Mass Spectrometry Department of Biochemistry Boston University School of Medicine Boston University Boston MA 02215 USA
| | - Miguel Srougi
- Laboratório de Investigação Médica da Disciplina de Urologia (LIM55) Faculdade de Medicina da FMUSP Universidade de Sao Paulo São Paulo 01000 Brazil
| | - Kathrin Stavenhagen
- Department of Molecular Sciences and Biomolecular Discovery and Design Research Centre (BDDRC) Macquarie University Sydney 2109 Australia
- Beth Israel Deaconess Medical Center Department of Surgery and Harvard Medical School Center for Glycoscience Harvard Medical School Boston MA 02215 USA
| | - Vignesh Venkatakrishnan
- Department of Rheumatology and Inflammation Research Institute of Medicine, Sahlgrenska Academy University of Gothenburg Gothenburg SE 405 30 Sweden
| | - Katherine Wongtrakul‐Kish
- Department of Molecular Sciences and Biomolecular Discovery and Design Research Centre (BDDRC) Macquarie University Sydney 2109 Australia
- Bioprocessing Technology Institute A*STAR Singapore 13862 Singapore
| | - Simone Diestel
- Institute of Nutrition and Food Sciences University of Bonn Bonn 53127 Germany
| | - Peter Hoffmann
- Future Industries Institute Mawson Lakes Campus, University of South Australia Adelaide 5005 Australia
| | - Niclas G. Karlsson
- Department of Medical Biochemistry and Cell Biology Institute of Biomedicine, Sahlgrenska Academy University of Gothenburg Gothenburg SE 405 30 Sweden
| | - Daniel Kolarich
- Institute for Glycomics, Griffith University Gold Coast 4222 Australia
| | - Mark P. Molloy
- Department of Molecular Sciences and Biomolecular Discovery and Design Research Centre (BDDRC) Macquarie University Sydney 2109 Australia
- Faculty of Medicine and Health Sydney School of Medicine Royal North Shore Hospital Sydney 2065 Australia
| | - Michael H. Muders
- Rudolf‐Becker‐Laboratory Institute of Pathology University Hospital Bonn Bonn 53127 Germany
| | - Martin K. Oehler
- Department of Gynaecological Oncology Royal Adelaide Hospital Adelaide 5000 Australia
| | - Nicolle H. Packer
- Department of Molecular Sciences and Biomolecular Discovery and Design Research Centre (BDDRC) Macquarie University Sydney 2109 Australia
- Institute for Glycomics, Griffith University Gold Coast 4222 Australia
- ARC Centre for Nanoscale Biophotonics Macquarie University Sydney 2109 Australia
| | - Giuseppe Palmisano
- Department of Parasitology, Institute of Biomedical Sciences University of São Paulo São Paulo 01000 Brazil
| | - Morten Thaysen‐Andersen
- Department of Molecular Sciences and Biomolecular Discovery and Design Research Centre (BDDRC) Macquarie University Sydney 2109 Australia
| |
Collapse
|
9
|
Tjondro HC, Loke I, Chatterjee S, Thaysen-Andersen M. Human protein paucimannosylation: cues from the eukaryotic kingdoms. Biol Rev Camb Philos Soc 2019; 94:2068-2100. [PMID: 31410980 DOI: 10.1111/brv.12548] [Citation(s) in RCA: 32] [Impact Index Per Article: 6.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/17/2018] [Revised: 07/10/2019] [Accepted: 07/17/2019] [Indexed: 12/11/2022]
Abstract
Paucimannosidic proteins (PMPs) are bioactive glycoproteins carrying truncated α- or β-mannosyl-terminating asparagine (N)-linked glycans widely reported across the eukaryotic domain. Our understanding of human PMPs remains limited, despite findings documenting their existence and association with human disease glycobiology. This review comprehensively surveys the structures, biosynthetic routes and functions of PMPs across the eukaryotic kingdoms with the aim of synthesising an improved understanding on the role of protein paucimannosylation in human health and diseases. Convincing biochemical, glycoanalytical and biological data detail a vast structural heterogeneity and fascinating tissue- and subcellular-specific expression of PMPs within invertebrates and plants, often comprising multi-α1,3/6-fucosylation and β1,2-xylosylation amongst other glycan modifications and non-glycan substitutions e.g. O-methylation. Vertebrates and protists express less-heterogeneous PMPs typically only comprising variable core fucosylation of bi- and trimannosylchitobiose core glycans. In particular, the Manα1,6Manβ1,4GlcNAc(α1,6Fuc)β1,4GlcNAcβAsn glycan (M2F) decorates various human neutrophil proteins reportedly displaying bioactivity and structural integrity demonstrating that they are not degradation products. Less-truncated paucimannosidic glycans (e.g. M3F) are characteristic glycosylation features of proteins expressed by human cancer and stem cells. Concertedly, these observations suggest the involvement of human PMPs in processes related to innate immunity, tumorigenesis and cellular differentiation. The absence of human PMPs in diverse bodily fluids studied under many (patho)physiological conditions suggests extravascular residence and points to localised functions of PMPs in peripheral tissues. Absence of PMPs in Fungi indicates that paucimannosylation is common, but not universally conserved, in eukaryotes. Relative to human PMPs, the expression of PMPs in plants, invertebrates and protists is more tissue-wide and constitutive yet, similar to their human counterparts, PMP expression remains regulated by the physiology of the producing organism and PMPs evidently serve essential functions in development, cell-cell communication and host-pathogen/symbiont interactions. In most PMP-producing organisms, including humans, the N-acetyl-β-hexosaminidase isoenzymes and linkage-specific α-mannosidases are glycoside hydrolases critical for generating PMPs via N-acetylglucosaminyltransferase I (GnT-I)-dependent and GnT-I-independent truncation pathways. However, the identity and structure of many species-specific PMPs in eukaryotes, their biosynthetic routes, strong tissue- and development-specific expression, and diverse functions are still elusive. Deep exploration of these PMP features involving, for example, the characterisation of endogenous PMP-recognising lectins across a variety of healthy and N-acetyl-β-hexosaminidase-deficient human tissue types and identification of microbial adhesins reactive to human PMPs, are amongst the many tasks required for enhanced insight into the glycobiology of human PMPs. In conclusion, the literature supports the notion that PMPs are significant, yet still heavily under-studied biomolecules in human glycobiology that serve essential functions and create structural heterogeneity not dissimilar to other human N-glycoprotein types. Human PMPs should therefore be recognised as bioactive glycoproteins that are distinctly different from the canonical N-glycoprotein classes and which warrant a more dedicated focus in glycobiological research.
Collapse
Affiliation(s)
- Harry C Tjondro
- Department of Molecular Sciences, Macquarie University, Sydney, New South Wales, 2109, Australia
| | - Ian Loke
- Department of Molecular Sciences, Macquarie University, Sydney, New South Wales, 2109, Australia.,Department of Biological Sciences, National University of Singapore, Singapore 117543, Singapore
| | - Sayantani Chatterjee
- Department of Molecular Sciences, Macquarie University, Sydney, New South Wales, 2109, Australia
| | - Morten Thaysen-Andersen
- Department of Molecular Sciences, Macquarie University, Sydney, New South Wales, 2109, Australia
| |
Collapse
|